| __timestamp | Pharming Group N.V. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 14182353 | 11768000 |
| Thursday, January 1, 2015 | 15503028 | 15152000 |
| Friday, January 1, 2016 | 16183585 | 19828000 |
| Sunday, January 1, 2017 | 22382849 | 25573000 |
| Monday, January 1, 2018 | 33038206 | 23634000 |
| Tuesday, January 1, 2019 | 31777040 | 38845000 |
| Wednesday, January 1, 2020 | 41464134 | 50523000 |
| Friday, January 1, 2021 | 67178053 | 75463000 |
| Saturday, January 1, 2022 | 52531000 | 105767000 |
| Sunday, January 1, 2023 | 68914000 | 167512000 |
In pursuit of knowledge
In the ever-evolving world of biotechnology, research and development (R&D) investments are the lifeblood of innovation. Over the past decade, Pharming Group N.V. and Xenon Pharmaceuticals Inc. have demonstrated a steadfast commitment to advancing medical science. From 2014 to 2023, Pharming Group N.V. increased its R&D spending by nearly 386%, while Xenon Pharmaceuticals Inc. saw an impressive 1,324% surge.
Pharming Group N.V. began with a modest investment in 2014, but by 2023, their R&D expenses had grown significantly, reflecting their dedication to pioneering treatments. Meanwhile, Xenon Pharmaceuticals Inc. has consistently outpaced its counterpart, with its R&D expenses peaking in 2023, showcasing a strategic focus on groundbreaking therapies. This trend underscores the critical role of R&D in driving biotech innovation and the potential for transformative healthcare solutions.
Comparing Innovation Spending: Johnson & Johnson and Pharming Group N.V.
Analyzing R&D Budgets: Bristol-Myers Squibb Company vs Xenon Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Xenon Pharmaceuticals Inc.
Pharming Group N.V. or Grifols, S.A.: Who Invests More in Innovation?
R&D Insights: How Pharming Group N.V. and Corcept Therapeutics Incorporated Allocate Funds
R&D Insights: How Pharming Group N.V. and MannKind Corporation Allocate Funds
Comparing Innovation Spending: Pharming Group N.V. and Novavax, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Research and Development: Comparing Key Metrics for Amneal Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc. or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Xenon Pharmaceuticals Inc. and Soleno Therapeutics, Inc.
Analyzing R&D Budgets: Xenon Pharmaceuticals Inc. vs Amphastar Pharmaceuticals, Inc.